CCS Initiatives
The CCS National Active Surveillance Study of Myocarditis and/or Pericarditis following
mRNA COVID-19 Vaccination (MYCOVACC) is a multi-centre, pan-Canadian study funded
by the Public Health Agency of Canada.
CCS Classification of Acute Myocardial Infarction (CCS-AMI)
On October 28, 2023, the Canadian Cardiovascular Society Classification of Acute Myocardial Infarction (CCS-AMI) – a new, never-before released classification of four stages of heart attack – was published in the Canadian Journal of Cardiology. A presentation at the Vascular 2023 conference in Montréal followed on October 29.